Share your story. Have you or someone you know received the drug Epcoritamab, now or in the past?

Epcoritamab is currently going through the NICE appraisal process (to treat relapsed or refractory large B-cell lymphoma), and it’s really helpful to have real patient/relative experiences included as part of the appraisal.
If you are happy to speak to our policy team and share your story, please leave a comment below :point_down:, and we will be in touch via direct message.